Microbiome in pancreatic cancer – What is new in 2024?

Microb Health Dis 2024; 6 : e1100
DOI: 10.26355/mhd_202410_1100

  Topic: Microbiota     Category:

Hohmann E.
Department of Medicine II, LMU University Hospital, Munich, Germany Close
, Ammer-Herrmenau C.
Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Centre, Goettingen, Germany Close
, Schulz C.
Department of Medicine II, LMU University Hospital, Munich, Germany Close
, Sirtl S.
Department of Medicine II, LMU University Hospital, Munich, Germany
simon.sirtl@med.uni-muenchen.de Close

Loading

Established and emerging prebiotics for gut microbiota

Microb Health Dis 2024; 6 : e1125
DOI: 10.26355/mhd_202410_1125

  Topic: Microbiota     Category:

Veljković M.
Innovation Centre of Faculty of Technology and Metallurgy, Belgrade, Serbia Close
, Vukoičić A.
Innovation Centre of Faculty of Technology and Metallurgy, Belgrade, Serbia Close
, Petrov Ivanković A.
Innovation Centre of Faculty of Technology and Metallurgy, Belgrade, Serbia Close
, Banjanac K.
Innovation Centre of Faculty of Technology and Metallurgy, Belgrade, Serbia
kbanjanac@tmf.bg.ac.rs Close

Loading

High altitude is associated with helicobacter pylori infection in a population of dyspeptic patients in Nepal – A research letter

Microb Health Dis 2024; 6 : e1113
DOI: 10.26355/mhd_20249_1113

Microbiota and metabolic dysfunction associated with steatotic liver disease

Microb Health Dis 2024; 6 : e1115
DOI: 10.26355/mhd_20249_1115

  Topic: Microbiota     Category:

Zhu Q.
Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium Close
, Francque S.
Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium
sven.francque@uza.be Close
, Kwanten W. J.
Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium Close

Loading

Role of probiotics to control gut-related diseases in animals

Microb Health Dis 2024; 6 : e1117
DOI: 10.26355/mhd_20249_1117

  Topic: Gut microbiota     Category:

Laila U.
Department of Eastern Medicine Government College, University Faisalabad, Faisalabad, Pakistan Close
, Varkey T. C.
Department of Neurology, University of Arizona College of Medicine, Phoenix, AZ, USA Close
, Akram M.
Department of Eastern Medicine Government College, University Faisalabad, Faisalabad, Pakistan Close
, Iftikhar M.
Department of Eastern Medicine Government College, University Faisalabad, Faisalabad, Pakistan Close
, Zainab R.
Department of Eastern Medicine Government College, University Faisalabad, Faisalabad, Pakistan Close
, Khalil T.
Department of Eastern Medicine Government College, University Faisalabad, Faisalabad, Pakistan Close
, Adonis S.
University of California Riverside, Patton State Hospital, Riverside, CA, USA Close
, Sołowski G.
Department of Molecular Biology and Genetics, Faculty of Science and Art, Bingol University, Bingol, Türkiye Close
, Ahmet Ozdemir F.
Department of Neurology, Neuroceuta, (Virgen de Africa Clinic), Ceuta, Spain Close
, Altable M.
Department of Neurology, Neuroceuta, (Virgen de Africa Clinic), Ceuta, Spain Close
, Zeitler C. M.
Arizona College of Osteopathic Medicine at Midwestern University, Glendale, AZ, USA Close
, Merhavy Z. I.
Ross University School of Medicine, Bridgetown, Barbados
ZackMerhavy@gmail.com Close

Loading

Helicobacter pylori and the microbiome in gastric cancer development and treatment: A year in review

Microb Health Dis 2024; 6 : e1031
DOI: 10.26355/mhd_20249_1031

  Topic: Helicobacter pylori     Category:

Vieira P.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Barbedo-Tavares M.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Figueiredo C.
i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
cfigueiredo@i3s.up.pt Close

Loading

Current considerations on Helicobacter pylori infection in children: A comprehensive review of the available evidence

Microb Health Dis 2024; 6 : e1034
DOI: 10.26355/mhd_20249_1034

  Topic: Helicobacter pylori     Category:

Rogalidou M.
Division of Gastroenterology and Hepatology, First Department of Pediatrics, National and Kapodistrian University of Athens, Agia Sofia Children’s Hospital, Athens, Greece
rogalidoum@yahoo.com Close
, Papadopoulou A.
Division of Gastroenterology and Hepatology, First Department of Pediatrics, National and Kapodistrian University of Athens, Agia Sofia Children’s Hospital, Athens, Greece Close

Loading

Review – H. pylori and non-malignant diseases

Microb Health Dis 2024; 6 : e1036
DOI: 10.26355/mhd_20249_1036

Review: trends in nanotherapeutics to manage Helicobacter pylori

Microb Health Dis 2024; 6 : e1038
DOI: 10.26355/mhd_20249_1038

  Topic: Helicobacter pylori     Category:

Chitas R.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Parreira P.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Close
, Martins M.C. L.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
cmartins@ineb.up.pt Close

Loading